Friday, June 26, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 846 of 1,261

  1. US 8568714

    Lys K endolysin is synergistic with lysostaphin against MRSA

    The United States of America, as represented by the Secretary of Agriculture · Granted Oct 29, 2013 · Expires Oct 24, 2033

    granted

  2. US 8568705

    Method for preparing branched functionalized polymers using branched polyol cores

    Nektar Therapeutics · Granted Oct 29, 2013 · Expires Oct 24, 2033

    granted

  3. CA 2870399

    POLYPEPTIDES DE PROFILINE VEGETALE DESTINES A ETRE UTILISES DANS L'IMMUNOTHERAPIE NON SPECIFIQUE D'ALLERGIES

    ALK ABELLO AS [DK] · Granted Oct 24, 2013 · Expires Oct 19, 2033

    granted

  4. EP 2651400

    ORALE RETARD-DARREICHUNGSFORMEN VON SCHWER LÖSLICHEN ARZNEIMITTELN UND IHRE VERWENDUNG

    CELGENE CORP [US] · Granted Oct 23, 2013 · Expires Oct 18, 2033

    granted

  5. US 8563269

    Modified antibody compositions, methods of making and using thereof

    CytomX Therapeutics, Inc. · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  6. US 8563716

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  7. US 8563512

    Neprilysin inhibitors

    Theravance, Inc. · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  8. US 8563026

    Protein-based artificial retinas

    UNIVERSITY OF CONNECTICUT · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  9. US 8562993

    Methods for treating GI syndrome and graft versus host disease

    The Board of Regents of the University of Texas System · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  10. US 8562944

    PAA nanoparticles for enhancement of tumor imaging

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  11. US 8562954

    Dental compositions with sensitivity relief

    DISCUS DENTAL, LLC · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  12. US 8563028

    Ophthalmic device, and method of use thereof, for increasing ocular boundary lubrication

    The Regents of the University of California · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  13. US 8563692

    Interferon-antibody fusion proteins demonstrating potent apoptotic and anti-tumor activities

    The Regents of the University of California · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  14. US 8562965

    Polymer derivatives comprising an acetal or ketal branching point

    Nektar Therapeutics · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  15. US 8563039

    Biomaterials consisting of sulphated hyaluronic acid and gellan to be used in the prevention of spinal adhesions

    Anika Therapeutics S.r.l. · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  16. US 8563314

    Methods and compositions for modulating PD1

    Sangamo Biosciences, Inc. · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  17. US 8563503

    Antibiotic, its nucleotide sequence, methods of construction and uses thereof

    PROTEIN DESIGN LAB, LTD. · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  18. US 8563515

    Tight junction protein modulators and uses thereof

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  19. US 8563569

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  20. US 8563575

    Fused heterocyclic compounds

    Takeda Pharmaceutical Company Limited · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  21. US 8563573

    Azaindole derivatives as CFTR modulators

    Vertex Pharmaceuticals Incorporated · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  22. US 8563576

    Tri-cyclic pyrazolopyridine kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  23. US 8563593

    Formulations of (R)-1-(2,2-difluorobenzo[D] [1,3] dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide

    Vertex Pharmaceuticals Incorporated · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  24. US 8563599

    Methods for synthesizing glycinols, glyceollins I and II, compositions of selected intermediates, and therapeutic uses thereof

    THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY OF AGRICULTURE · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.